Paris, March 14^th, 2022

Visiomed Group (FR0013481835 - ALVMG), a key player in the connected healthcare sector, today announces proposed governance changes instigated by its new major shareholder, investment company PARK PARTNERS GP.

PARK PARTNERS became Visiomed Group's financial partner in February 2021 and has enabled the Company to raise €25 million to date in the form of Convertible Bonds with attached warrants financing¹. These funds were mainly used to finance BewellConnect's telemedicine solutions business based on VisioCheck® and, above all, the acquisition of Smart Salem, the first digital medical center accredited by the Dubai Ministry of Health (DHA) and the General Directorate of Residency and Foreign Affairs (GDRFA) in the United Arab Emirates. As announced, solely due to Smart Salem's contribution, Visiomed Group expects to reach new record consolidated revenue in 2022, exceeding the €19.0 million achieved in 2020².

Against this backdrop, PARK PARTNERS GP considers that the Company's current market capitalization does not reflect the actual value of its assets or its development potential and has therefore decided to keep hold of the securities resulting from the latest subscribed bond conversions. To the best of the Company's knowledge, PARK PARTNERS GP currently holds 48.9% of Visiomed Group's share capital³ and has become a major shareholder pursuing a long-term vision in order to unveil the value of its investment.

PARK PARTNERS GP also supports the termination of the Convertible Bonds with attached warrants financing agreement in line with Visiomed Group's commitment⁴ and wishes to enhance corporate governance to help unveil its intrinsic value. As such, PARK PARTNERS GP has proposed the appointment of four new members of the Visiomed Group Board of Directors. These appointments have been approved by the Board of Directors and will be put to the vote by the Visiomed Group shareholders at the next Ordinary and Extraordinary General Meeting on Tuesday, April 19^th, 2022⁵.

PARK PARTNERS GP Managing Director Simon Le Reste said: “Visiomed Group has succeeded in strengthening its financial position and creating value by allocating our financing to the Smart Salem acquisition, a project that immediately generated significant revenues with strong growth potential. As proof of our trust, we are now supporting Visiomed Group as a long-term major shareholder and are delighted to propose the appointment of highly talented new directors.”

About VISIOMED GROUP

Founded in 2007, VISIOMED GROUP relies on a long experience in the health sector to invest in innovative health technologies and services in France and abroad.

The Group now has two wholly-owned subsidiaries:

• BewellConnect, created in 2014, pioneer in connected health and teleconsultation solutions
  
  BewellConnect offers an enriched technological universe, both in medical devices and software, making it possible to respond to all telehealth use cases: enriched and assisted teleconsultation, home telemonitoring, hospital monitoring, tele-expertise, teleassistance and tele-regulation.
  
  BewellConnect's flagship product, VisioCheck, is the first telemedicine station weighing less than 300g for healthcare professionals, available in a case, station or modular health space.
  
  BewellConnect is now deploying its solutions in France and abroad.

• Smart Salem, the first digital medical analysis center accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates
  
  The Smart Salem offer is based on know-how in medical analysis, radiology and data analysis and processing to detect nearly 35 diseases in 7 minutes in a patient (in particular HIV, hepatitis and tuberculosis) by offering reliable results, readability and exceptional patient experience enabled by advanced artificial intelligence and virtual reality technologies.
  
  Smart Salem's “Medical Fitness Assessment” offer resulting from this know-how thus makes it possible to obtain a residence or work visa in the space of 30 minutes compared to 10 to 15 days in historical health centers.
  
  Smart Salem is a technological platform offering many growth opportunities, as shown by the opening of the second center in Dubai in September 2022 and the authorization received for the opening of a third center, planned to open in the first quarter of 2023.

Based in Paris, VISIOMED GROUP is listed on Euronext Growth (ALVMG). More information on visiomed.fr, smartsalem.ae and www.bewell-connect.com.

CONTACTS

© Visiomed Group SA 2022. The brands mentioned are the property of their respective authors. Reproduction prohibited, even partial, without prior authorization.

Disclaimer

This press release contains non-factual information, including but not limited to certain statements regarding upcoming results and other future events. These statements are based on the Company management's current guidance and assumptions. They incorporate known and unknown risks and uncertainties that could result in material differences versus forecast earnings, profitability and events. Furthermore, Visiomed Group and its shareholders, affiliates, directors, officers, advisors and employees have not verified the accuracy of, and make no representations or warranties regarding, the statistical data or forward-looking information contained in this press release that originates or is derived from third-party sources or industry publications. Such statistical data and forward-looking information are used solely for information purposes in this press release.

¹ After a successful restructuring, Visiomed Group pursues acquisition policy and financing to establish leading player in connected healthcare
² After a record year in 2021, Smart Salem forecasts further sustained growth in 2022
³ Based on share capital comprising 202,457,180 shares as of February 28^th, 2022
⁴ Visiomed Group announces termination of convertible bond financing scheme
⁵ The notice of meeting, published in the French legal announcement gazette (Balo) today, may be found on the Visiomed Group website. Documentation regarding the April 19^th, 2022 Ordinary and Extraordinary General Meeting will be published on the website as it is drafted.